很高興回答妳的問題。
妳的範圍有點逛，我幫妳調查了下周圍的朋友，找了壹篇文獻。
如果妳用的著就拿去吧。壹***找了2篇名字是：
《Use of IDEF modeling to develop an information management system for drug and alcohol outpatient treatment clinics》
《FDA Automated Drug Information Management System》還有這些文獻都需要寫reference~(參考)的意思，不然他們會不高興的。呵呵..
希望對妳有幫助！
Use of IDEF modeling to develop an information management system for drug and alcohol outpatient treatment clinics
Hoffman, Kenneth
Proc. SPIE Vol. 2499, p. 96-105, Health Care Technology Policy II: The Role of Technology in the Cost of Health Care: Providing the Solutions, Warren S. Grundfest; Ed.
Few information systems create a standardized clinical patient record in which there are discrete and concise observations of patient problems and their resolution. Clinical notes usually are narratives which don't support an aggregate and systematic outcome analysis. Many programs collect information on diagnosis and coded procedures but are not focused on patient problems. Integrated definition (IDEF) methodology has been accepted by the Department of Defense as part of the Corporate Information Management Initiative and serves as the foundation that establishes a need for automation. We used IDEF modeling to describe present and idealized patient care activities. A logical IDEF data model was created to support those activities. The modeling process allows for accurate cost estimates based upon performed activities, efficient collection of relevant information, and outputs which allow real- time assessments of process and outcomes. This model forms the foundation for a prototype automated clinical information system (ACIS).
《使用法語國家法律協會建模開發壹個信息管理系統的藥物和酒精的門診治療診所》
霍夫曼，肯尼思
過程。 SPIE成交量。 2499年，第96-105 ，衛生保健技術政策二：技術作用的醫療保健費用：提供的解決方案，沃倫南Grundfest ;版。
幾個信息系統建立壹個標準化的臨床病歷，其中有離散和簡潔的意見病人的問題及其解決辦法。臨床註意到通常說明不支持系統的信息匯總和分析結果。許多程序收集信息的診斷和編碼的程序，但沒有集中在病人的問題。綜合定義（法語國家法律協會）的方法已接受了美國國防部的壹部分，企業信息管理倡議並作為基礎，建立了必要的自動化。我們使用了法語國家法律協會模型來描述當前和理想化病人護理活動。壹個合乎邏輯的法語國家法律協會的數據模型的成立是為了支持這些活動。在建模過程中可以準確的成本估算為基礎進行的活動，有效地收集有關資料，和產出，使實時評估的過程和成果。該模型的基礎形式的原型自動臨床信息系統（ ACIS ） 。
第二篇：FDA Automated Drug Information Management System
The Automated Drug Information Management System (ADIMS) is being developed as an integrated, fully electronic information management system for the receipt, validation, evaluation, and dissemination of drug safety and effectiveness data. As the core enterprise architecture for FDA's pre-market drug review process, all systems involved in that process will either be replaced or integrated into ADIMS. The system will be seamless, with single sign-on access to information and tools used in daily decision-making. The Document Archiving, Reporting, and Regulatory Tracking System (DARRTS) will be the backbone of the system. Over fifty current large and small systems will be integrated as ADIMS, including the Corporate Oracle Management Information System (COMIS), the Electronic Document Room (EDR), the Division File System (DFS), and systems within the FACTS@FDA program. As the volume of technologically advanced electronic information coming into FDA increases, the need for a robust information management system increases. In addition to facilitating drug review and approval, an integrated data management system to collect and evaluate electronic clinical data facilitates the identification of trends and other critical information (i.e., potential product safety issues). Also, the validation and back-up capabilities of ADIMS will facilitate data verification and correction with increased efficiency. Currently all systems across FDA are being reviewed for potential migration to the MedWatch Plus, FASTAR, EDSR, Product Quality Program investment in FY10. Consolidating current stovepipe and stand-alone drug information systems into a cohesive, easily supportable platform will allow reviewers to be able to access information from one place and will improve accessibility and reduce redundancy. Reducing redundant manual data entry and consolidating access to data will improve data quality and improve performance objectives as well as save time and resources required to keep multiple systems updated. Thus, ADIMS directly supports the goal of e-Government by creating efficient electronic access to the most up-to-date and complete information within the Agency and the HHS strategic goal of Improve health care quality, safety, cost and value by allowing real-time transfer of information. This, plus the system's capabilities of accepting electronic submission, will improve the FDA's responsiveness to consumers, industry, and healthcare providers.
《美國FDA藥物自動化信息管理系統》
自動藥品信息管理系統（ ADIMS ）正在開發的壹個綜合的，全面的電子信息管理系統，負責接收，驗證，評價和傳播的藥物安全性和有效性的數據。為核心的企業架構，美國FDA的上市前藥品審查過程中，所有系統參與這壹進程將被取代或整合到ADIMS 。該系統將無縫的，與單壹登錄獲取信息和使用的工具在日常決策。該文件存檔，報告和管理跟蹤系統（ DARRTS ）將是該系統的骨幹。 50多個大，小電流系統將被整合為ADIMS ，包括甲骨文公司管理信息系統（ COMIS ） ，電子文檔室（增強數據率） ，該司文件系統（ DFS ） ，和系統內的輸電@ FDA的計劃。隨著數量的技術先進的電子信息進入美國FDA的增加，需要有壹個強有力的信息管理系統增加。除了促進藥物審查和批準，以綜合數據管理系統，以收集和評估電子臨床數據有助於查明趨勢和其他重要信息（即潛在的產品安全問題） 。此外，審定和後備能力ADIMS將有利於數據的驗證和校正與提高效率。目前，所有系統在美國FDA目前正在審查潛在的移民到MedWatch另外， FASTAR ， EDSR ，產品質量計劃投資FY10 。鞏固現有的煙囪和獨立的藥物信息系統納入壹個統壹的，容易支持的平臺將允許審評能夠訪問信息從壹個地方，並會改善無障礙環境和減少冗余。減少多余的人工數據輸入和鞏固獲得的數據將提高數據質量和提高績效目標以及節省時間和資源必須保持多個系統更新。因此， ADIMS直接支持的目標，電子政務，建立高效的電子進入最最新的和完整的信息的機構和衛生與公眾服務部的戰略目標改善保健服務質量，安全，成本和價值，允許實時時間傳遞信息。這壹點，再加上系統的能力，接受以電子方式提交，將改善美國的反應對消費者，工業和醫療保健機構。